Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?

[Figure: see text]

Detalles Bibliográficos
Autores principales: Mann, Douglas L., Kelly, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034482/
https://www.ncbi.nlm.nih.gov/pubmed/30062156
http://dx.doi.org/10.1016/j.jacbts.2017.07.004
_version_ 1783337890998124544
author Mann, Douglas L.
Kelly, Daniel P.
author_facet Mann, Douglas L.
Kelly, Daniel P.
author_sort Mann, Douglas L.
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-6034482
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60344822018-07-30 Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure? Mann, Douglas L. Kelly, Daniel P. JACC Basic Transl Sci Editorial Comment [Figure: see text] Elsevier 2017-08-04 /pmc/articles/PMC6034482/ /pubmed/30062156 http://dx.doi.org/10.1016/j.jacbts.2017.07.004 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial Comment
Mann, Douglas L.
Kelly, Daniel P.
Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
title Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
title_full Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
title_fullStr Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
title_full_unstemmed Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
title_short Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
title_sort empagliflozin and the prevention of heart failure: will reverse translation lead to new paradigms for the treatment of heart failure?
topic Editorial Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034482/
https://www.ncbi.nlm.nih.gov/pubmed/30062156
http://dx.doi.org/10.1016/j.jacbts.2017.07.004
work_keys_str_mv AT manndouglasl empagliflozinandthepreventionofheartfailurewillreversetranslationleadtonewparadigmsforthetreatmentofheartfailure
AT kellydanielp empagliflozinandthepreventionofheartfailurewillreversetranslationleadtonewparadigmsforthetreatmentofheartfailure

Ejemplares similares